Postpartum Hemorrhage: From Proven Tools to Real-World Impact
AlignMNH shared a post on LinkedIn:
“Excessive bleeding after childbirth, or postpartum hemorrhage (PPH), remains a leading cause of maternal death worldwide—responsible for nearly 45,000 deaths in 2023.
A new commentary in BJOG—co-authored by our colleague Lisa Noguchi — reflects on progress since the launch of the WHO Roadmap to Combat PPH (2023–2030) and outlines why urgent, coordinated action is needed to save women’s lives.
Key highlights:
- Global maternal deaths have declined by 41% since 2000, but progress remains uneven—women in sub-Saharan Africa and South Asia continue to face disproportionate risk.
- Proven solutions—like uterotonics, tranexamic acid, and the PPH treatment bundle—are still underused due to policy, financing, and supply chain gaps.
- The Roadmap has catalyzed important gains: rapid uptake of the E-MOTIVE trial evidence into WHO guidelines, adoption of PPH bundles in multiple countries, and the launch of the first World PPH Day to sustain global advocacy.
But systemic inequities, fragile financing, and geopolitical challenges still stall progress.
The message is clear: we have the tools, evidence, and solutions. What matters now is translating them into sustained action everywhere.”
Title: World Postpartum Haemorrhage Day: Renewing the Global Call to End Deaths From Postpartum Haemorrhage
Read the full article here.
Stay informed with Hemostasis Today.
-
Oct 10, 2025, 16:15Roshan PK: Breaking Down Pulmonary Embolism Treatment By Risk Level
-
Oct 10, 2025, 12:21Chris Barber Echoes PPTA’s Call to Recognize the Lifesaving Work of Plasma Collection Teams Worldwide
-
Oct 10, 2025, 12:14William Aird: Thalassemia Trait is a Quiet Experiment of Nature
-
Oct 9, 2025, 19:53Wilfried Dinh: Top 10 Thrombosis And Antithrombotic Therapy Papers Of 2024
-
Oct 9, 2025, 13:12Abdul Mannan - Ferritin After IV Iron: Timing Matters
-
Oct 10, 2025, 12:23Bhavya Venkatesh: Talin Autoinhibition Is Required For Normal Hemostasis
-
Oct 10, 2025, 12:19Divyaswathi Citla Sridhar: Excited to Share Our Multicenter Study on Platelet Function Disorders, Now Published
-
Oct 10, 2025, 12:18Roberta Gualtierotti: We Evaluated Different Variables of the Cleaved HK Method in C1-Inhibitor Defects
-
Oct 10, 2025, 12:17Jamie Madrigal And The Team - Mathematical Analysis Of Emicizumab: Affinity-Driven Complex Formation And Lipid-Surface Reactions
-
Oct 10, 2025, 03:09Giuseppe Lippi: We Show Here That Red Light Therapy Offers Promise in High-Risk Patients
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 10, 2025, 03:10Marilena Vrana: Plasma-Derived Medicines Are a Clear Example of Why A One-Size-Fits-All Approach Won’t Work
-
Oct 10, 2025, 03:07Nancy Di Salvo: It's IPAW 2025, How Could I Not Take a Moment to Thank Every Single Plasma Donor Out There?
-
Oct 10, 2025, 03:06Anita Brikman: Increasing Awareness of The Ongoing Need for Plasma Donors Is Vital to Ensuring Patient Access and Continuity of Care
-
Oct 10, 2025, 03:04Stephen Cornelissen: A New Plasma Drop Has Been Added to Lifeblood’s Blood Supply Tracker
-
Oct 10, 2025, 02:12Bethany Samuelson Bannow Welcomed to Department of Hematology and Medical Oncology at the Cancer Institute Cleveland Clinic